Yipinhong Pharmaceutical Co Ltd Class A (300723) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.008x

Based on the latest financial reports, Yipinhong Pharmaceutical Co Ltd Class A (300723) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥14.81 Million ≈ $2.17 Million USD) by net assets (CN¥1.80 Billion ≈ $263.56 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Yipinhong Pharmaceutical Co Ltd Class A defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Yipinhong Pharmaceutical Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Yipinhong Pharmaceutical Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Yipinhong Pharmaceutical Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yipinhong Pharmaceutical Co Ltd Class A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shanghai Luoman Lighting Technologies Inc. SHG:605289	0.015x
Korea Circuit Co. Ltd. KO:007810	-0.013x
Banner Corporation NASDAQ:BANR	0.062x
Guangdong Ellington Electronics Technology Co Ltd SHG:603328	0.053x
Avepoint Inc NASDAQ:AVPT	0.055x
Freshworks Inc NASDAQ:FRSH	0.069x
Hefei Urban Construction Development Co Ltd SHE:002208	-0.260x
Beijing Toread Outdoor Product SHE:300005	0.003x

Annual Cash Flow Conversion Efficiency for Yipinhong Pharmaceutical Co Ltd Class A (2013–2025)

The table below shows the annual cash flow conversion efficiency of Yipinhong Pharmaceutical Co Ltd Class A from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see Yipinhong Pharmaceutical Co Ltd Class A market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.41 Billion ≈ $205.84 Million	CN¥46.01 Million ≈ $6.73 Million	0.033x	+111.50%
2024-12-31	CN¥1.94 Billion ≈ $283.28 Million	CN¥-550.42 Million ≈ $-80.54 Million	-0.284x	-261.26%
2023-12-31	CN¥2.60 Billion ≈ $380.16 Million	CN¥458.05 Million ≈ $67.03 Million	0.176x	-19.70%
2022-12-31	CN¥2.17 Billion ≈ $316.92 Million	CN¥475.53 Million ≈ $69.59 Million	0.220x	+1.16%
2021-12-31	CN¥2.02 Billion ≈ $295.35 Million	CN¥438.10 Million ≈ $64.11 Million	0.217x	+17.91%
2020-12-31	CN¥1.50 Billion ≈ $218.77 Million	CN¥275.22 Million ≈ $40.27 Million	0.184x	-12.06%
2019-12-31	CN¥1.34 Billion ≈ $196.17 Million	CN¥280.65 Million ≈ $41.07 Million	0.209x	+14.00%
2018-12-31	CN¥1.30 Billion ≈ $190.13 Million	CN¥238.60 Million ≈ $34.91 Million	0.184x	+44.01%
2017-12-31	CN¥1.11 Billion ≈ $162.20 Million	CN¥141.35 Million ≈ $20.68 Million	0.128x	-70.61%
2016-12-31	CN¥336.50 Million ≈ $49.24 Million	CN¥146.01 Million ≈ $21.37 Million	0.434x	+152.00%
2015-12-31	CN¥200.66 Million ≈ $29.36 Million	CN¥34.55 Million ≈ $5.06 Million	0.172x	+151.17%
2014-12-31	CN¥127.52 Million ≈ $18.66 Million	CN¥8.74 Million ≈ $1.28 Million	0.069x	-90.62%
2013-12-31	CN¥185.61 Million ≈ $27.16 Million	CN¥135.68 Million ≈ $19.85 Million	0.731x	--

About Yipinhong Pharmaceutical Co Ltd Class A

SHE:300723 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.21 Billion

CN¥15.10 Billion CNY

Market Cap Rank

#5992 Global

#1243 in China

Share Price

CN¥33.42

Change (1 day)

+1.95%

52-Week Range

CN¥29.56 - CN¥80.53

All Time High

CN¥80.53